Compare PRPO & OPTT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PRPO | OPTT |
|---|---|---|
| Founded | N/A | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Electric Utilities: Central |
| Sector | Industrials | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 42.0M | 56.4M |
| IPO Year | 2000 | 2006 |
| Metric | PRPO | OPTT |
|---|---|---|
| Price | $29.51 | $0.17 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $1.50 |
| AVG Volume (30 Days) | 97.5K | ★ 4.5M |
| Earning Date | 05-12-2026 | 03-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 92.15 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $24,049,000.00 | $3,737,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $221.57 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 29.77 | N/A |
| 52 Week Low | $14.28 | $0.13 |
| 52 Week High | $33.63 | $0.72 |
| Indicator | PRPO | OPTT |
|---|---|---|
| Relative Strength Index (RSI) | 64.36 | 42.48 |
| Support Level | $21.45 | $0.13 |
| Resistance Level | $33.63 | $0.45 |
| Average True Range (ATR) | 2.13 | 0.02 |
| MACD | 0.50 | 0.00 |
| Stochastic Oscillator | 69.43 | 26.88 |
Precipio Inc is a healthcare biotechnology company focused on cancer diagnostics. Its objective is to enhance diagnostic accuracy & accessibility while building a sustainable business model that supports ongoing innovation. The company operates Clinical Laboratory Improvement Amendments laboratories in both New Haven, Connecticut, & Omaha, Nebraska, providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. The company operates in a single segment, which includes two divisions: the Pathology Services Division & the Products Division. The Pathology Services provides specialized cancer diagnostic testing services. The pathology services division specializes in diagnostic testing focused mainly on hematologic cancers.
Ocean Power Technologies Inc provides intelligent maritime solutions and services that enable safer, cleaner, and more productive ocean operations for the defense and security, oil and gas, science and research, and offshore wind markets. It provides ocean data collection and reporting, marine power, offshore communications, and Maritime Domain Awareness System (MDAS) products, integrated solutions, and consulting services. The company offers its products and services to a wide range of customers, including those in government and offshore energy, oil and gas, construction, wind power, and other industries. The company has operations in North and South America, Europe, Asia and Australia.